QQQ   417.04 (-1.50%)
AAPL   165.06 (-1.19%)
MSFT   399.78 (-1.11%)
META   484.49 (-3.45%)
GOOGL   154.04 (-1.26%)
AMZN   174.75 (-2.49%)
TSLA   149.39 (-0.36%)
NVDA   810.69 (-4.25%)
AMD   149.25 (-3.76%)
NIO   3.83 (-4.25%)
BABA   68.81 (-0.10%)
T   16.37 (+0.24%)
F   12.12 (+0.50%)
MU   107.74 (-3.74%)
GE   149.22 (-2.43%)
CGC   8.13 (+3.83%)
DIS   112.07 (-0.32%)
AMC   3.23 (+10.62%)
PFE   25.78 (+1.54%)
PYPL   62.19 (+0.14%)
XOM   120.10 (+1.33%)
QQQ   417.04 (-1.50%)
AAPL   165.06 (-1.19%)
MSFT   399.78 (-1.11%)
META   484.49 (-3.45%)
GOOGL   154.04 (-1.26%)
AMZN   174.75 (-2.49%)
TSLA   149.39 (-0.36%)
NVDA   810.69 (-4.25%)
AMD   149.25 (-3.76%)
NIO   3.83 (-4.25%)
BABA   68.81 (-0.10%)
T   16.37 (+0.24%)
F   12.12 (+0.50%)
MU   107.74 (-3.74%)
GE   149.22 (-2.43%)
CGC   8.13 (+3.83%)
DIS   112.07 (-0.32%)
AMC   3.23 (+10.62%)
PFE   25.78 (+1.54%)
PYPL   62.19 (+0.14%)
XOM   120.10 (+1.33%)
QQQ   417.04 (-1.50%)
AAPL   165.06 (-1.19%)
MSFT   399.78 (-1.11%)
META   484.49 (-3.45%)
GOOGL   154.04 (-1.26%)
AMZN   174.75 (-2.49%)
TSLA   149.39 (-0.36%)
NVDA   810.69 (-4.25%)
AMD   149.25 (-3.76%)
NIO   3.83 (-4.25%)
BABA   68.81 (-0.10%)
T   16.37 (+0.24%)
F   12.12 (+0.50%)
MU   107.74 (-3.74%)
GE   149.22 (-2.43%)
CGC   8.13 (+3.83%)
DIS   112.07 (-0.32%)
AMC   3.23 (+10.62%)
PFE   25.78 (+1.54%)
PYPL   62.19 (+0.14%)
XOM   120.10 (+1.33%)
QQQ   417.04 (-1.50%)
AAPL   165.06 (-1.19%)
MSFT   399.78 (-1.11%)
META   484.49 (-3.45%)
GOOGL   154.04 (-1.26%)
AMZN   174.75 (-2.49%)
TSLA   149.39 (-0.36%)
NVDA   810.69 (-4.25%)
AMD   149.25 (-3.76%)
NIO   3.83 (-4.25%)
BABA   68.81 (-0.10%)
T   16.37 (+0.24%)
F   12.12 (+0.50%)
MU   107.74 (-3.74%)
GE   149.22 (-2.43%)
CGC   8.13 (+3.83%)
DIS   112.07 (-0.32%)
AMC   3.23 (+10.62%)
PFE   25.78 (+1.54%)
PYPL   62.19 (+0.14%)
XOM   120.10 (+1.33%)

Lantern Pharma (LTRN) News Today

$5.60
-0.17 (-2.95%)
(As of 01:27 PM ET)
SourceHeadline
finance.yahoo.com logoLantern Pharma Inc. (LTRN)
finance.yahoo.com - April 17 at 2:21 PM
morningstar.com logoLantern Pharma Inc Ordinary Shares
morningstar.com - April 13 at 10:13 AM
marketbeat.com logoLantern Pharma (NASDAQ:LTRN) Trading Down 13.8%
marketbeat.com - April 12 at 12:55 AM
marketbeat.com logoShort Interest in Lantern Pharma Inc. (NASDAQ:LTRN) Expands By 191.1%
marketbeat.com - April 12 at 12:14 AM
investing.com logoLantern Pharma Inc (LTRN)
investing.com - April 10 at 1:29 PM
marketbeat.com logoLantern Pharma Inc. to Post FY2024 Earnings of ($2.06) Per Share, HC Wainwright Forecasts (NASDAQ:LTRN)
marketbeat.com - March 21 at 8:06 AM
seekingalpha.com logoLantern Pharma Inc. (LTRN) Q4 2023 Earnings Call Transcript
seekingalpha.com - March 20 at 7:31 PM
marketbeat.com logoLantern Pharma Inc. (NASDAQ:LTRN) Expected to Earn Q1 2024 Earnings of ($0.43) Per Share
marketbeat.com - March 20 at 5:45 AM
msn.com logoLTRN: 2023 Results
msn.com - March 19 at 6:11 PM
markets.businessinsider.com logoH.C. Wainwright Reaffirms Their Hold Rating on Lantern Pharma (LTRN)
markets.businessinsider.com - March 19 at 1:10 PM
finance.yahoo.com logoLantern Pharma Inc. (NASDAQ:LTRN) Q4 2023 Earnings Call Transcript
finance.yahoo.com - March 19 at 1:10 PM
investorplace.com logoLTRN Stock Earnings: Lantern Pharma Beats EPS for Q4 2023
investorplace.com - March 18 at 10:00 PM
benzinga.com logoRecap: Lantern Pharma Q4 Earnings
benzinga.com - March 18 at 7:43 PM
finance.yahoo.com logoLantern Pharma Inc Reports Progress and Financials for FY 2023
finance.yahoo.com - March 18 at 7:43 PM
businesswire.com logoLantern Pharma Reports Fourth Quarter & Fiscal Year 2023 Financial Results and Business Highlights
businesswire.com - March 18 at 4:02 PM
marketbeat.com logoLantern Pharma (LTRN) to Release Earnings on Monday
marketbeat.com - March 17 at 1:23 AM
marketbeat.com logoLantern Pharma Inc. (NASDAQ:LTRN) Short Interest Update
marketbeat.com - March 16 at 11:05 PM
marketwatch.com logoLantern Pharma Up 20% After Dosing Initiated in Trial for Cancer Drug Developed with AI
marketwatch.com - March 16 at 10:04 PM
finance.yahoo.com logoLTRN May 2024 5.000 call
finance.yahoo.com - March 16 at 5:03 PM
finance.yahoo.com logoLTRN Apr 2024 12.500 call
finance.yahoo.com - March 16 at 7:01 AM
benzinga.com logoLantern Pharma Earnings Preview
benzinga.com - March 15 at 4:00 PM
finance.yahoo.com logoLantern Pharma Announces Initial Patients Dosed in First-In-Human Clinical Trial for AI-Guided Drug-Candidate, LP-284
finance.yahoo.com - March 15 at 10:59 AM
finance.yahoo.com logoLTRN Mar 2024 10.000 call
finance.yahoo.com - March 14 at 10:35 PM
marketbeat.com logoLantern Pharma (LTRN) to Release Quarterly Earnings on Monday
marketbeat.com - March 12 at 9:59 AM
businesswire.com logoLantern Pharma to Report Fourth Quarter and Fiscal Year 2023 Operating & Financial Results on March 18th, 2024 at 4:30 p.m. ET
businesswire.com - March 11 at 7:30 AM
finance.yahoo.com logoLTRN Oct 2024 5.000 put
finance.yahoo.com - March 8 at 2:55 PM
finance.yahoo.com logoLTRN Apr 2024 2.500 call
finance.yahoo.com - March 8 at 2:55 PM
finance.yahoo.com logoLTRN Mar 2024 7.500 call
finance.yahoo.com - March 7 at 1:08 PM
finance.yahoo.com logoLantern To Participate in H.C Wainwright & Co.’s (HCW) 1st Annual Artificial Intelligence Based Drug Discovery & Development Virtual Conference
finance.yahoo.com - March 5 at 8:39 AM
businesswire.com logoLantern To Participate in H.C Wainwright & Co.'s (HCW) 1st Annual Artificial Intelligence Based Drug Discovery & Development Virtual Conference
businesswire.com - March 5 at 8:01 AM
finance.yahoo.com logoLantern Pharma's A.I. Platform, RADR®, Surpasses 60 Billion Data Points – Anticipates Reaching 100 Billion Data Points in 2024, Paving the Way for Enhanced Cancer Therapy Innovations and Expedited Development Timelines
finance.yahoo.com - March 4 at 12:37 PM
msn.com logoAfter Taiwan's striking lantern festival, school kids help clean up the mess
msn.com - February 28 at 2:01 AM
benzinga.com logoLantern Pharma Stock (NASDAQ:LTRN) Dividends: History, Yield and Dates
benzinga.com - February 23 at 8:54 AM
finance.yahoo.com logoLTRN: Spotlighting ADCs & Another Orphan
finance.yahoo.com - February 20 at 1:05 PM
finance.yahoo.com logoLantern Pharma Advances Unique ADC (Antibody Drug Conjugate) Program Across Multiple Solid Tumor Cancers
finance.yahoo.com - February 15 at 9:47 AM
businesswire.com logoLantern Pharma Advances Unique ADC (Antibody Drug Conjugate) Program Across Multiple Solid Tumor Cancers
businesswire.com - February 15 at 8:01 AM
finance.yahoo.com logoHere's Why We're Not Too Worried About Lantern Pharma's (NASDAQ:LTRN) Cash Burn Situation
finance.yahoo.com - February 5 at 4:01 PM
finance.yahoo.com logoStarlight Therapeutics, a Subsidiary of Lantern Pharma Focused on CNS & Brain Cancers, Announces Dr. Marc Chamberlain as Chief Medical Officer
finance.yahoo.com - January 17 at 9:28 AM
markets.businessinsider.com logoLantern Pharma: FDA Grants Orphan Drug Designation For LP-284 In High-Grade B-cell Lymphomas
markets.businessinsider.com - November 30 at 12:26 PM
finance.yahoo.com logoFDA Grants Lantern Pharma Orphan Drug Designation for Drug Candidate LP-284 in High-Grade B-cell Lymphomas (HGBL)
finance.yahoo.com - November 30 at 12:26 PM
finance.yahoo.com logoLantern Pharma Inc. (NASDAQ:LTRN) Q3 2023 Earnings Call Transcript
finance.yahoo.com - November 10 at 3:01 PM
markets.businessinsider.com logoAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Lantern Pharma (LTRN), LifeMD (LFMD) and Calliditas Therapeutics (CALT)
markets.businessinsider.com - November 9 at 11:57 PM
finance.yahoo.com logoLTRN: Three Assets in the Clinic in 3Q:23
finance.yahoo.com - November 9 at 1:56 PM
msn.com logoLantern Pharma GAAP EPS of -$0.29
msn.com - November 8 at 7:42 PM
benzinga.com logoLantern Pharma: Q3 Earnings Insights
benzinga.com - November 8 at 7:42 PM
finance.yahoo.com logoLantern Pharma Reports Third Quarter 2023 Financial Results and Operational Highlights
finance.yahoo.com - November 8 at 7:42 PM
finance.yahoo.com logoLantern Pharma Inc (LTRN) Reports Q3 2023 Financial Results and Provides Operational Updates
finance.yahoo.com - November 8 at 7:42 PM
finance.yahoo.com logoLantern Pharma to Report Third Quarter 2023 Operating & Financial Results on November 8th, 2023 at 4:30 p.m. ET
finance.yahoo.com - November 1 at 12:48 PM
finance.yahoo.com logoLantern Pharma to Present at the ThinkEquity Conference on October 19 at 1:30 p.m. ET
finance.yahoo.com - October 10 at 10:08 AM
markets.businessinsider.com logoLantern Pharma Publishes Pre-clinical Efficacy Data Of Drug Candidate LP-184 In Glioblastoma
markets.businessinsider.com - October 3 at 12:24 PM
Get Lantern Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for LTRN and its competitors with MarketBeat's FREE daily newsletter.

2024's Must-Have Guide: Master Crypto Investment Today (Ad)

The cryptocurrency revolution is here with Bitcoin soaring past the $70,000 milestone—a clear indicator of the booming digital currency market. Are you prepared to navigate these exciting yet complex waters? Introducing "Navigating the Future: A Comprehensive Guide to Cryptocurrency Investments in 2024." This free digital guide is your essential resource for understanding and capitalizing on cryptocurrency investments, tailored for both newcomers and seasoned investors. (**By clicking the link you are subscribing to The Conservative Investor Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy.)

Click here to download your crypto report

LTRN Media Mentions By Week

LTRN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

LTRN
News Sentiment

0.00

0.52

Average
Medical
News Sentiment

LTRN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

LTRN Articles
This Week

2

1

LTRN Articles
Average Week

Get Lantern Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for LTRN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:LTRN) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners